ASX Announcements
ACWs $3.9m entitlement offer opens & letters distribute
Non-Renounceable Issue, Letter to Shareholders
- May 15, 2024
- 9 pages
Notification regarding unquoted securities - ACW
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities)
- May 14, 2024
- 6 pages
Application for quotation of securities - ACW
Appendix 2A (Application for Quotation of Securities)
- May 14, 2024
- 6 pages
ACW Clinical Trials Science Forum 23 May registration detail
Company Administration - Other, Web Casts
- May 13, 2024
- 3 pages
October 2020
Bell Potter raising for Alzheimer's drug hopeful Actinogen
ASX-listed Actinogen Medical is in front of potential investors seeking a $10 million equity injection to fund a trial for its Alzheimer's drug.
- Sarah Thompson, Anthony Macdonald and Tim Boyd
December 2017
Actinogen Medical raises $5.2m for Alzheimer's treatment
Alzheimer's disease is the second biggest killer of Australians, but investors have just bet $5.3 million that an ASX-listed company has the cure.
- Michael Bailey
January 2016
- Opinion
In innovation and biotech let's party like it's 1998
Conditions may be bad but in 1997 they were also bad and 1998 was expected to be far worse, but then the sharemarket boomed.
- Updated
- Martin Rogers
